Neuro-Oncology

Top Story

FDA grants accelerated approval to Keytruda for solid tumors with specific biomarker

May 23, 2017

The FDA today granted accelerated approval to pembrolizumab for adults and children with unresectable or metastatic, microsatellite instability–high or mismatch repair–deficient solid tumors.

This indication for pembrolizumab (Keytruda, Merck) — the FDA’s first tissue/site-agnostic approval — includes patients with solid tumors that have progressed following prior treatment and who have no satisfactory alternative treatment options, as well as patients with colorectal cancer that has progressed following treatment with fluoropyrimidine, oxaliplatin and irinotecan.

Conquer Cancer Foundation of ASCO to present awards

May 21, 2017
The Conquer Cancer Foundation of ASCO announced the recipients of its Special Merit Awards. Conquer Cancer Foundation Merit Awards support oncology trainees who are…

Seven updates in neuro-oncology

May 19, 2017
The National Brain Tumor Society is calling for volunteers, patients, families, public policy advocates and physicians to act and join the society’s “brain…
In the Journals Plus

Rare cancers represent 20% of US cancer diagnoses

May 19, 2017
Rare malignancies accounted for about one in five cancer diagnoses in the United States from 2009 to 2013, according to an American Cancer Society report published in…
CNE CME

The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »
Video
Meeting News Coverage

VIDEO: Diabetes, obesity associated with chemotherapy-induced neuropathy

June 22, 2016
More »
Featured
ASCO Annual Meeting

ASCO Annual Meeting

CME

Polycythemia Vera: Aligning Real World Practices With Current Best Practices

This activity is supported by an independent educational grant from Incyte Corporation.

Ruben A. Mesa, MD, provides practical insights into treating polycythemia vera in this video series. In addition to…
More »
FDA News

FDA grants accelerated approval to Keytruda for solid tumors with specific biomarker

May 23, 2017
The FDA today granted accelerated approval to pembrolizumab for adults and children with unresectable or metastatic, microsatellite…

Conquer Cancer Foundation of ASCO to present awards

May 21, 2017
The Conquer Cancer Foundation of ASCO announced the recipients of its Special Merit Awards. Conquer Cancer Foundation Merit Awards support oncology…

Seven updates in neuro-oncology

May 19, 2017
The National Brain Tumor Society is calling for volunteers, patients, families, public policy advocates and physicians to act and join the…

In the Journals Plus

Rare cancers represent 20% of US cancer diagnoses

May 19, 2017
Rare malignancies accounted for about one in five cancer diagnoses in the United States from 2009 to 2013, according to an American Cancer Society…

Investigational vaccine confers ‘striking’ benefit in glioblastoma

May 17, 2017
The addition of an investigational vaccine to chemotherapy led to unexpectedly longer survival for patients with glioblastoma, according to results…

FDA News

FDA grants breakthrough therapy designation to entrectinib for NTRK fusion–positive solid tumors

May 15, 2017
The FDA granted breakthrough therapy designation to entrectinib for the treatment of NTRK fusion–positive locally advanced or metastatic solid…

FDA News

FDA grants orphan drug designation to larotrectinib for solid tumors with NTRK gene fusions

May 12, 2017
The FDA granted orphan drug designation to larotrectinib for the treatment of solid tumors with neurotrophic tyrosine receptor kinase–fusion…

Loyola Medicine radiation oncologist receives distinguished service award

May 6, 2017
Edward Melian, MD, a radiation oncologist with Loyola Medicine, received the Chicago Radiological Society’s Distinguished Service Award. The…

In the Journals Plus

First live births less common among cancer survivors

May 1, 2017
Survivors of childhood and adolescent cancer were less likely as adults to have a first live birth than adults who never had cancer, according to…

In the Journals Plus

Cranial radiotherapy linked to subsequent meningiomas in childhood cancer survivors

April 27, 2017
The diagnosis of meningioma in childhood cancer survivors exposed to cranial radiotherapy increased risk for neurologic morbidity, according to a…

More Headlines »
Advertisement
Advertisement